Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation

85Citations
Citations of this article
57Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Allergy is caused by immune effector cells, including mast cells and basophils. Cellular signaling that activates these effector cells is regulated by different inhibitory receptors on their surface. We show that human leukocyte immunoglobulin (Ig)-like receptor (LILR) B2 and its mouse orthologue, paired Ig-like receptor (PIR)-B, constitutively associate to major histocompatibility complex (MHC) class I on the same cell surface (in cis). The IgE-mediated effector responses were augmented in β2-microglobulin (β2m) and PIR-B-deficient mast cells. In addition, the increased cytokine production of β2m-deficient mast cells was not affected by the co-culture with MHC class I-positive mast cells, showing that less cis interaction between PIR-B and MHC class I on mast cells led to the increased cytokine release. Thus, the constitutive cis binding between LILRB2 or PIR-B and MHC class I has an essential role in regulating allergic responses. JEM © The Rockefeller University Press.

Cite

CITATION STYLE

APA

Masuda, A., Nakamura, A., Maeda, T., Sakamoto, Y., & Takai, T. (2007). Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation. Journal of Experimental Medicine, 204(4), 907–920. https://doi.org/10.1084/jem.20060631

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free